US BIOLOGIC

US BIOLOGIC is a biotechnology and healthcare startup based in the United States, founded in 2012 with the overarching purpose of "Delivering Disease Prevention." The company aims to revolutionize global disease prevention through the development of orally delivered vaccines. By offering safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans, US BIOLOGIC has positioned itself at the forefront of innovation in the healthcare industry. The company collaborates with esteemed experts to integrate proven technologies into their oral-delivery platform and further commercializes these products by providing essential funding, regulatory support, manufacturing, and distribution expertise. The most recent milestone for US BIOLOGIC was the Series A investment secured on 02 February 2020, with the backing of Launch Tennessee. This investment represents a significant endorsement of the company's potential and underlines the confidence of external stakeholders in its pioneering approach to disease prevention. Overall, US BIOLOGIC stands as a promising player in the biotechnology and healthcare sectors, with its innovative solutions and strategic collaborations positioning it for future success and impact in the global arena of disease prevention.